Table I.
Summary of short-term studies' PROM.
| Author | LOE | Follow-up mo, mean (range) | Number B shoulders | Treatment | ASES, mean (SD) [range] | Constant, mean (SD) [range] | SST (SD) [range] | DASH (SD) [range] | SANE (SD) [range] | PSS (SD) [range] | VAS (SD) [range] |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Onlay glenoid TSA | |||||||||||
| Gerber et al (2009)14 | 4 | 42 (NR) | 14 | Asymmetric reaming with pegged all-polyethylene glenoid | Pre: 39 (NR) [22 to 77] Post: 78 (NR) [58-99] | ||||||
| Alentorn-Geli et al (2018)1 comparison TSA vs. RSA | 4 | 43 (NR) | 15 | TSA with asymmetric reaming and capsular plication | Post: 91.2 (6.7) [NR] | Post: 10.6 (NR) [NR] | |||||
| Orvets et al (2018)40 | 4 | 50 (24 to 97) | 59 | Asymmetric reaming with all-polyethylene glenoid | Pre: 35.4 (14.3) [3.3 to 90] Post: 84.3 (14.0) [53.3 to 100] Improvement: 48.9 (17.5) [0 to 93.3] | Pre: 4.5 (2.6) [0 to 12] Post: 9.1 (2.2) [4 to 12] Improvement: 4.6 (2.4) [−3 to 9] | Pre: 7.4 (.17) [2 to 10] Post: 1.4 (1.9) [0-10] Improvement: 6 (2.2) [−10 to 1.5] | ||||
| Sabesan et al (2013)43 | 4 | 53 (26 to 110) | 9 | TSA with PGBG. All-polyethylene pegged or keel glenoid | Pre: 38.7 (NR) [19-52] Post: 79.4 (NR) [17 to 100] | ||||||
| Nicholson et al (2017)37 | 4 | 48 (24 to 126) | 28 | TSA with PGBG. All-polyethylene pegged or keeled glenoid | Pre: 39 (18) [NR] Post: 90 (10) [NR] | Pre: 4 (3) [NR] Post: 10 (2) [NR] | Pre: 5 (2) [NR] Post: 1 (1) [NR] | ||||
| Stephens et al (2017)48 | 4 | 24∗ | 19 | TSA with stepped augmented all-polyethylene glenoid | Pre: 39 (NR) [NR] Post: 91 (NR) [NR] | Pre: 2.4 (NR) [NR] Post: 10.6 (NR) [NR] | Pre: 6.3 (NR) [NR] Post: 0.3 (NR) [NR] | ||||
| Ho et al (2018)22 | 4 | 28 (24 to 68)† | 71 | TSA with stepped augmented all-polyethylene glenoid | Pre: 49 (NR) [5 to 66] Post: 94 (NR) [51 to 100]† | ||||||
| Priddy et al (2019)41 | 3 | 39 (24 to 72) | 33 | TSA with wedged augmented all-polyethylene glenoid | Pre: 45.3 (12.3) [NR] Post: 86.8 (14.7) [NR] Improvement: 41.5 (18.5) | Pre: 47.6 (15) [NR] Post: 82.7 (12.9) [NR] Improvement: 36.0 (15.9) | Pre: 5.0 (1.8) [NR] Post: 1.1 (1.7) [NR] Improvement: 4.0 (2.7) | ||||
| RSA | |||||||||||
| Mizuno et al (2013)35 | 4 | 54 (24 to 139) | 27 | RSA (10 required bone grafting) | Pre: 31 (NR) [NR] Post: 76 (NR) [NR] |
||||||
| Harmsen et al (2017)20 | 4 | 34 (24 to 89) | 26 | BIO-RSA | Pre: 29.5 (NR) [NR] Post: 89.0 (NR) [NR] Improvement: 59.5 |
Pre: 6.7 (NR) [NR] Post: 0.3 (NR) [NR] Improvement: 6.4 |
|||||
| Alentorn-Geli et al (2018)1 | 4 | 35 (NR) | 16 | RSA (4 patients required bone graft) | Post: 8.5 (NR) [NR] | ||||||
| Hemiarthroplasty | |||||||||||
| Hsu et al (2016)25 | 4 | 24 (NR)minimum follow-up | 33 | Hemiarthroplasty with concentric glenoid reaming (n = 24) | Pre: 4.8 (2.3) [NR] Post: 10.0 (2.3) [NR] |
Pre: 42.5 (21.5) [NR] Post: 80.5 (17.6) [NR] |
|||||
| Getz et al (2017)15 | 4 | 24 (NR) minimum follow-up | 24 | Hemiarthroplasty with concentric glenoid reaming | Post: 10.4 (NR) [6.0 to 12.0] only included patients not undergoing revision | Post: 74.5 (NR) [1 to 95] only included patients not undergoing revision | Post: 82.9 (NR) [38.2 to 99.0] only included patients not undergoing revision | ||||
| Inlay glenoid | |||||||||||
| Cvetanovich et al (2019)10 | 4 | 40 (23 to 60) | 12 | Humeral head resurfacing with inlay glenoid | Pre: 25.1 (20.4) [NR] Post: 80.4 (13.6) [NR] |
Pre: 5.4 (3.1) [NR] Post: 1.6 (2.3) [NR] |
|||||
| Egger et al (2019)11 | 4 | 42.6 (24 to 74) | 24 | Humeral head resurfacing with inlay glenoid | Pre: 42.2 (17.1) [33.1 to 51.3] Post: 88.6 (9.9) [83.3 to 93.9] |
Pre: 6.4 (2.2) [5.3 to 7.5] Post: 1.0 (1.4) [0.3 to 1.7] |
PROM, Patient-reported outcome measures; LOE, level of evidence; ASES, American Shoulder and Elbow Surgeons score; SD, standard deviation; SST, Simple Shoulder Test; DASH, Disability of the Arm, Shoulder, and Hand; SANE, Single Assessment Numeric Evaluation; PSS, Penn Shoulder Score; VAS, Visual Analog Scale; TSA, total shoulder arthroplasty; PGBG, posterior glenoid bone graft; Pre, preoperative; NR, not reported; Post, postoperative; RSA, reverse shoulder arthroplasty; BIO-RSA, bony increased offset-reverse shoulder arthroplasty.
∗
Minimum 24-mo follow-up.
†
Reported as median.